Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma

Clinical trial NCT00350961 · COMPLETED

Trial details

NCT number: NCT00350961
Sponsor: Rigshospitalet, Denmark
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cholangiocarcinoma

Start date: 2004-06-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.